Union Budget 2026: What Rs 10,000 crore BioPharma Shakti means for India’s health sector
Published on: Feb. 1, 2026, 11:38 a.m. | Source: THE WEEK
The BioPharma Shakti initiative aims to strengthen research, clinical trials, and regulatory capacity amid India’s rising non-communicable disease burden
